Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-031508

Chief Medical Officer acquired 24,336 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Karen L. · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 1 in the form +24,336 24,336 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +151,799 151,799 D
2022-05-23 Grant or award : show line 3 in the form Employee Stock Option (right to buy) +1,365,449 1,365,449 D
Loading xslF345X03/doc4.xml…